13.6 C
New York
Saturday, September 24, 2022

Compass Pathways (CMPS) gains 1.33% in Active Trading on August 18

Compass Pathways Plc – ADR (NASDAQ: CMPS) gained to close at $31.23 Wednesday after gaining $0.41 (1.33%) on volume of 502,686 shares. The stock ranged from a high of $31.94 to a low of $30.56 while Compass Pathways’s market cap now stands at $1,247,024,237.

About Compass Pathways Plc – ADR

COMPASS Pathways plc is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Its focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. It is pioneering the development of a new model of psilocybin therapy, in which its proprietary formulation of synthetic psilocybin, COMP360, is administered in conjunction with psychological support. COMP360 has been designated a Breakthrough Therapy by the US Food and Drug Administration (FDA), for treatment-resistant depression (TRD), and it is currently conducting a phase IIb clinical trial of psilocybin therapy for TRD, in 22 sites across Europe and North America. It is headquartered in London, UK, with offices in New York, USA. Its vision is a world of mental wellbeing.

Visit Compass Pathways Plc – ADR’s profile for more information.

About The Nasdaq Stock Market

The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world’s leading exchange for options volume and is home to the five largest US companies – Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information on Compass Pathways Plc – ADR and to follow the company’s latest updates, you can visit the company’s profile page here:
Compass Pathways Plc – ADR’s Profile
. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Geely Automobile Warns of Short-Term Semiconductor Hit But Reiterates Annual Sales Target
House Democratic Leaders Plan To Vote on Budget Next Week
Walmart Easily Beats Quarterly Estimates, Raises Annual Same-Store Sales Forecast
US Health Officials To Recommend COVID-19 Booster Shots for All
Biden Fights To Contain Fallout Over Troop Withdrawal From Afghanistan
Texas Governor Greg Abbott Tests Positive for COVID-19
Fed Chair Powell Says COVID-19 Impact on Economic Recovery Remains Unclear
TSA Extends Face Mask Requirement on Airlines Until January 2022

Source link

Related Articles


Please enter your comment!
Please enter your name here

one × five =

Stay Connected


Latest Articles